A biomaterial that can mimic certain behaviors within biological tissues could advance regenerative medicine, disease modeling, soft robotics and more, according to researchers at Penn State.
‘Faster together’: AstraZeneca breaks into clinical services business with new company launch, lining up two CRO partners to start
LONDON — AstraZeneca has launched a new global health tech business, Evinova, after seeing a gap in the market to reduce the time and cost